Korea Enbrel biosimilar approval a milestone for Merck and Samsung JV
A copycat version of Amgen’s Enbrel has been approved in Korea, marking the first regulatory success for Merck & Co and Samsung Bioepis' biosimilar joint venture.
Archives for September 10, 2015
Boulder-move? AstraZeneca buys ex-Amgen plant to boost biologics network
AstraZeneca has bought a commercial manufacturing plant in Colorado from Amgen to bolster its biologics network.
Polpharma hires key member of Sandoz's US Zarxio launch team as biosimilar head
Polpharma has hired one of the architects of Sandoz’s recent US Zarxio launch to lead its biologics division.
Trial supplies of candidate breast cancer radio-mAb still stable after 5 years says study
Trial supplies of a radio-immunotherapy drug made by Areva Med in compliance with GMP are stable five years after they were produced according to the results of new analysis.